Top

Published in:

01-12-2020 | Mood Disorders | Original Paper

Internalized HIV Stigma and Pain among Women with HIV in the United States: The Mediating Role of Depressive Symptoms

Authors: Kaylee B. Crockett, T. Alinea Esensoy, Mallory O. Johnson, Torsten B. Neilands, Mirjam-Colette Kempf, Deborah Konkle-Parker, Gina Wingood, Phyllis C. Tien, Mardge Cohen, Tracey E. Wilson, Carmen H. Logie, Oluwakemi Sosanya, Michael Plankey, Elizabeth Golub, Adaora A. Adimora, Carrigan Parish, Sheri D. Weiser, Janet M. Turan, Bulent Turan

Published in: AIDS and Behavior | Issue 12/2020

Abstract

Pain is common in women with HIV, though little research has focused on psychosocial experiences contributing to pain in this population. In the present study we examined whether internalized HIV stigma predicts pain, and whether depressive symptoms mediate this relationship among women with HIV. Data were drawn from the Women’s Interagency HIV Study (WIHS), for 1,364 women with HIV who completed three study visits between 2015 and 2016. We used a sequential longitudinal design to assess the relationship between internalized HIV stigma at time 1 on pain at time 3 through depressive symptoms at time 2. Analyses revealed internalized HIV stigma was prospectively associated with greater pain, B = 5.30, 95% CI [2.84, 7.60]. The indirect effect through depressive symptoms supported mediation, B = 3.68, 95% CI [2.69, 4.79]. Depression is a modifiable risk factor that can be addressed to improve pain prevention and intervention for women with HIV.

Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53(11):1130–9. https://doi.org/10.1093/cid/cir626.CrossRefPubMed

Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. The Lancet. 2013;382(9903):1525–33. https://doi.org/10.1016/S0140-6736(13)61809-7.CrossRef

Balderson BH, Grothaus L, Harrison RG, McCoy K, Mahoney C, Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care. 2013;25(4):451–8. https://doi.org/10.1080/09540121.2012.712669.CrossRefPubMed

Merlin J. Chronic pain in patients with HIV infection: what clinicians need to know. Top Antivir Med. 2015;23(3):120–4.PubMed

Goodin BR, Owens MA, White DM, et al. Intersectional health-related stigma in persons living with HIV and chronic pain: implications for depressive symptoms. AIDS Care. 2018;30(sup2):66–73. https://doi.org/10.1080/09540121.2018.1468012.CrossRefPubMedPubMedCentral

Merlin JS, Westfall AO, Raper JL, et al. Pain, Mood, and Substance Abuse in HIV. JAIDS. 2012;61(2):164–70. https://doi.org/10.1097/QAI.0b013e3182662215.CrossRefPubMed

Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12(9):1004–166. https://doi.org/10.1016/j.jpain.2011.04.002.CrossRefPubMedPubMedCentral

Richardson JL, Heikes B, Karim R, Weber K, Anastos K, Young M. Experience of pain among women with advanced HIV disease. AIDS Patient Care STDS. 2009;23(7):503–11. https://doi.org/10.1089/apc.2008.0128.CrossRefPubMedPubMedCentral

Jiao JM, So E, Jebakumar J, George MC, Simpson DM, Robinson-Papp J. Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization. Pain. 2016;157(4):931–7. https://doi.org/10.1097/j.pain.0000000000000462.CrossRefPubMed

10.

Sharma A, Hoover DR, Shi Q, et al. Frequent occurrence of pain and prescription opioid use for treatment of pain among women with and at risk for HIV infection. AIDS Behav. 2018;22(6):2008–177. https://doi.org/10.1007/s10461-017-1828-0.CrossRefPubMedPubMedCentral

11.

Goodin BR, Owens MA, Yessick LR, et al. Detectable Viral Load May Be Associated with Increased Pain Sensitivity in Persons Living with HIV: Preliminary Findings. Pain Med. 2017;18(12):2289–95. https://doi.org/10.1093/pm/pnx057.CrossRefPubMedPubMedCentral

12.

Merlin JS, Zinski A, Norton WE, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014;14(3):207–16. https://doi.org/10.1111/papr.12052.CrossRefPubMed

13.

Merlin JS, Westfall AO, Chamot E, et al. Pain is independently associated with impaired physical function in HIV-infected patients. Pain Med. 2013;14(12):1985–93. https://doi.org/10.1111/pme.12255.CrossRefPubMed

14.

Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, ART adherence, and virologic failure. JAIDS. 2012;61(2):164–70. https://doi.org/10.1097/QAI.0b013e3182662215.CrossRefPubMed

15.

Surratt HL, Kurtz SP, Levi-Minzi MA, Cicero TJ, Tsuyuki K, O'grady CL. Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive patients. AIDS Patient Care STDs. 2015; 29(4): 186–192.

16.

Aouizerat BE, Miaskowski CA, Gay C, et al. Risk factors and symptoms associated with pain in HIV-infected adults. J Assoc Nurses AIDS Care. 2010;21(2):125–33. https://doi.org/10.1016/j.jana.2009.10.003.CrossRefPubMedPubMedCentral

17.

Parker R, Stein DJ, Jelsma J. Pain in people living with HIV/AIDS: a systematic review. J Int AIDS Soc. 2014;17(1):18719. https://doi.org/10.7448/IAS.17.1.18719.CrossRefPubMedPubMedCentral

18.

Scott W, Arkuter C, Kioskli K, et al. Psychosocial factors associated with persistent pain in people with HIV: a systematic review with meta-analysis. Pain. 2018;159(12):2461–76. https://doi.org/10.1097/j.pain.0000000000001369.CrossRefPubMedPubMedCentral

19.

DeWall CN, MacDonald G, Webster GD, et al. Acetaminophen reduces social pain: behavioral and neural evidence. Psychol Sci. 2010;21(7):931–7. https://doi.org/10.1177/0956797610374741.CrossRefPubMed

20.

MacDonald G, Leary MR. Why does social exclusion hurt? The relationship between social and physical pain. Psychol Bull. 2005;131(2):202–23. https://doi.org/10.1037/0033-2909.131.2.202.CrossRefPubMed

21.

Kross E, Berman MG, Mischel W, Smith EE, Wager TD. Social rejection shares somatosensory representations with physical pain. Proc Natl Acad Sci USA. 2011;108(15):6270–5. https://doi.org/10.1073/pnas.1102693108.CrossRefPubMed

22.

Woo C-W, Koban L, Kross E, et al. Separate neural representations for physical pain and social rejection. Nat Commun. 2014;5:5380. https://doi.org/10.1038/ncomms6380.CrossRefPubMedPubMedCentral

23.

Link BG, Phelan JC. Conceptualizing stigma. Ann Rev Sociol. 2001;27(1):363–85.CrossRef

24.

Mahajan AP, Sayles JN, Patel VA, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(Suppl 2):S67–S79. https://doi.org/10.1097/01.aids.0000327438.13291.62.CrossRefPubMedPubMedCentral

25.

Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103(5):813–21. https://doi.org/10.2105/AJPH.2012.301069.CrossRefPubMedPubMedCentral

26.

Wadley AL, Pincus T, Evangeli M. A preliminary analysis of the association between perceived stigma and HIV-related pain. Afr J Prim Health Care Fam Med. 2019;11(1):e1–e5. https://doi.org/10.4102/phcfm.v11i1.1647.CrossRefPubMed

27.

Turan B, Crockett KB, Buyukcan-Tetik A, et al. Buffering internalization of HIV stigma: implications for treatment adherence and depression. JAIDS. 2019;80(3):284–91. https://doi.org/10.1097/QAI.0000000000001915.CrossRefPubMed

28.

Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM. Framing mechanisms linking HIV-related stigma, adherence to treatment, and health outcomes. Am J Public Health. 2017;107(6):863–9. https://doi.org/10.2105/AJPH.2017.303744.CrossRefPubMedPubMedCentral

29.

Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160.CrossRef

30.

Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–95. https://doi.org/10.1007/s10461-013-0437-9.CrossRefPubMedPubMedCentral

31.

Boone MR, Cook SH, Wilson PA. Sexual identity and HIV status influence the relationship between internalized stigma and psychological distress in black gay and bisexual men. AIDS Care. 2016;28(6):764–70. https://doi.org/10.1080/09540121.2016.1164801.CrossRefPubMedPubMedCentral

32.

Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town. South Africa Soc Sci Med. 2007;64(9):1823–31. https://doi.org/10.1016/j.socscimed.2007.01.006.CrossRefPubMed

33.

Mak WW, Poon CY, Pun LY, Cheung SF. Meta-analysis of stigma and mental health. Soc Sci Med. 2007;65(2):245–61. https://doi.org/10.1016/j.socscimed.2007.03.015.CrossRefPubMed

34.

Turan B, Rice WS, Crockett KB, et al. Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression. AIDS. 2019;33(3):571–6. https://doi.org/10.1097/QAD.0000000000002071.CrossRefPubMedPubMedCentral

35.

Crockett KB, Kalichman SC, Kalichman MO, Cruess DG, Katner HP. Experiences of HIV-related discrimination and consequences for internalised stigma, depression and alcohol use. Psychol Health. 2019;34(7):796–810. https://doi.org/10.1080/08870446.2019.1572143.CrossRefPubMedPubMedCentral

36.

Turan B, Smith W, Cohen MH, et al. Mechanisms for the negative effects of internalized HIV-related stigma on antiretroviral therapy adherence in women: the mediating roles of social isolation and depression. JAIDS. 2016;72(2):198–205. https://doi.org/10.1097/QAI.0000000000000948.CrossRefPubMed

37.

Chang MH, Hsu JW, Huang KL, et al. Bidirectional association between depression and fibromyalgia syndrome: a nationwide longitudinal study. J Pain. 2015;16(9):895–902. https://doi.org/10.1016/j.jpain.2015.06.004.CrossRefPubMed

38.

Elliot TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 2003;4(4):331–9. https://doi.org/10.1111/j.1526-4637.2003.03040.x.CrossRef

39.

Arnow BA, Hunkeler EM, Blasey CM, et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom Med. 2006;68(2):262–8. https://doi.org/10.1097/01.psy.0000204851.15499.fc.CrossRefPubMed

40.

Carr EC, Nicky Thomas V, Wilson-Barnet J. Patient experiences of anxiety, depression and acute pain after surgery: a longitudinal perspective. Int J Nurs Stud. 2005;42(5):521–30. https://doi.org/10.1016/j.ijnurstu.2004.09.014.CrossRefPubMed

41.

Moayedi M, Davis KD. Theories of pain: from specificity to gate control. J Neurophysiol. 2012;109(1):5–12. https://doi.org/10.1152/jn.00457.2012.CrossRefPubMed

42.

Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007;133(4):581–624. https://doi.org/10.1037/0033-2909.133.4.581.CrossRefPubMed

43.

Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–45. https://doi.org/10.1001/archinte.163.20.2433.CrossRefPubMed

44.

Adimora AA, Ramirez C, Benning L, et al. Cohort profile: the women’s interagency HIV study (WIHS). Int J Epidemiol. 2018;47(2):393–394i. https://doi.org/10.1093/ije/dyy021.CrossRefPubMedPubMedCentral

45.

Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.CrossRef

46.

Bunn JY, Solomon SE, Miller C, Forehand R. Measurement of stigma in people with HIV: a reexamination of the HIV Stigma Scale. AIDS Educ Prev. 2007;19(3):198–208. https://doi.org/10.1521/aeap.2007.19.3.198.CrossRefPubMed

47.

Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef

48.

Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188(10):662–70. https://doi.org/10.1097/00005053-200010000-00004.CrossRefPubMed

49.

Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;473–483.

50.

Muthén LK, Muthén BO. Mplus. The comprehensive modelling program for applied researchers: user’s guide. Muthén & Muthén, 1998.

51.

MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7(1):83–104.CrossRef

52.

Velly AM, Mohit S. Epidemiology of pain and relation to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:159–67.CrossRef

53.

Ebirim LN, Otokwala JG. Inadequate pain relief in ambulatory patients with human immunodeficiency virus disease in Port Harcourt. HIV AIDS. 2013;5:199–203. https://doi.org/10.2147/HIV.S45150.CrossRef

54.

Smith D, Wilkie R, Uthman O, Jordan JL, McBeth J. Chronic pain and mortality: a systematic review. PLoS ONE. 2014;9(6):e99048. https://doi.org/10.1371/journal.pone.0099048.CrossRefPubMedPubMedCentral

55.

Baugher AR, Beer L, Fagan JL, et al. Prevalence of internalized HIV-related stigma among HIV-infected adults in care, United States, 2011–2013. AIDS Behav. 2017;21(9):2600–2608.

56.

Pantelic M, Sprague L, Stangl AL. It’s not “all in your head”: critical knowledge gaps on internalized HIV stigma and a call for integrating social and structural conceptualizations. BMC Infect Dis. 2019;19(1):210. https://doi.org/10.1186/s12879-019-3704-1.CrossRefPubMedPubMedCentral

57.

Dworkin RH, O’connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–251.

58.

Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009;31(3):206–19. https://doi.org/10.1016/j.genhosppsych.2008.12.006.CrossRefPubMed

59.

Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1):CD006605.

60.

Semenkovich K, Chockalingam R, Scherrer JF, et al. Prescription opioid analgesics increase risk of major depression: new evidence, plausible neurobiological mechanisms and management to achieve depression prophylaxis. Mo Med. 2014;111(2):148–54.PubMedPubMedCentral

61.

Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557–64.PubMedPubMedCentral

62.

Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–1321.

63.

Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66. https://doi.org/10.1037/a0035747.CrossRefPubMed

64.

Merlin JS, Westfall AO, Long D, et al. A randomized pilot trial of a novel behavioral intervention for chronic pain tailored to individuals with HIV. AIDS Behav. 2018;22(8):2733–42. https://doi.org/10.1007/s10461-018-2028-2.CrossRefPubMedPubMedCentral

65.

Turan JM, Elafros MA, Logie CH, et al. Challenges and opportunities in examining and addressing intersectional stigma and health. BMC Med. 2019;17(1):7. https://doi.org/10.1186/s12916-018-1246-9.CrossRefPubMedPubMedCentral

Title: Internalized HIV Stigma and Pain among Women with HIV in the United States: The Mediating Role of Depressive Symptoms
Authors: Kaylee B. Crockett
T. Alinea Esensoy
Mallory O. Johnson
Torsten B. Neilands
Mirjam-Colette Kempf
Deborah Konkle-Parker
Gina Wingood
Phyllis C. Tien
Mardge Cohen
Tracey E. Wilson
Carmen H. Logie
Oluwakemi Sosanya
Michael Plankey
Elizabeth Golub
Adaora A. Adimora
Carrigan Parish
Sheri D. Weiser
Janet M. Turan
Bulent Turan
Publication date: 01-12-2020
Publisher: Springer US
Keywords: Mood Disorders
Human Immunodeficiency Virus
Affective Disorder
Published in: AIDS and Behavior / Issue 12/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-020-02919-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2020

Socioeconomic Predictors of Transactional Sex in a Cohort of Adolescent Girls and Young Women in Malawi: A Longitudinal Analysis

Conceptualizing LGBT Stigma and Associated HIV Vulnerabilities Among LGBT Persons in Lesotho

Australian Gay and Bisexual Men Who Use Condoms, PrEP or Rarely Practise HIV Risk Reduction with Casual Sex Partners: An Analysis of National, Behavioural Surveillance Data, 2017–2018

Medical Mistrust and the PrEP Cascade Among Latino Sexual Minority Men

Learning from People with HIV: Their Insights are Critical to Our Response to the Intersecting COVID-19 and HIV Pandemics in Africa

Presence of Older Adolescents in the Household is Associated with Depressive Symptoms Among Women Living with HIV in Kenya

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials